CLINICAL PROFILE, SIDE EFFECTS AND OUTCOME OF NON SMALL CELL LUNG CANCER (NSCLC) TREATED WITH ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS (EGFR-TKI) IN MALAYSIAN PATIENTS: Abstract ID – 807


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles